Indication
Polymyalgia rheumatica
Polymyalgia rheumatica is a systemic inflammatory rheumatic disorder that predominantly affects adults aged 50 years and older. Read more about Polymyalgia rheumatica
101 drugs 75 manufacturers
Drugs that treat it
Common Polymyalgia rheumatica therapies.
PREDNISONE
PREDNISONE
PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOSPHATE
RAYOS (prednisone)
PREDNISONE
PREDNISONE
PREDNISONE INTENSOL (prednisone)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPolymyalgia rheumatica is a systemic inflammatory rheumatic disorder that predominantly affects adults aged 50 years and older.
It is clinically defined by subacute, bilateral aching pain and severe morning stiffness lasting longer than 45 minutes, localized primarily to the shoulder girdles, pelvic girdles, and neck.
Pathophysiologically, the condition involves periarticular inflammation characterized by bursitis, tenosynovitis, and synovitis, frequently accompanied by marked elevations in acute-phase reactants such as erythrocyte sedimentation rate and C-reactive protein, and it is closely associated with giant cell arteritis.
- nih.gov
Polymyalgia rheumatica is a systemic inflammatory rheumatic disorder that predominantly affects adults aged 50 years and older It is clinically defined by subacute, bilateral aching pain and severe morning stiffness lasting longer than 45 minutes, localized primarily to the shoulder girdles, pelvic girdles, and neck Pathophysiologically, the condition involves periarticular inflammation characterized by bursitis, tenosynovitis, and synovitis, frequently accompanied by marked elevations in acute-...
- nih.gov
Polymyalgia rheumatica is a systemic inflammatory rheumatic disorder that predominantly affects adults aged 50 years and older Pathophysiologically, the condition involves periarticular inflammation characterized by bursitis, tenosynovitis, and synovitis, frequently accompanied by marked elevations in acute-phase reactants such as erythrocyte sedimentation rate and C-reactive protein, and it is closely associated with giant cell arteritis
- merckmanuals.com
It is clinically defined by subacute, bilateral aching pain and severe morning stiffness lasting longer than 45 minutes, localized primarily to the shoulder girdles, pelvic girdles, and neck Pathophysiologically, the condition involves periarticular inflammation characterized by bursitis, tenosynovitis, and synovitis, frequently accompanied by marked elevations in acute-phase reactants such as erythrocyte sedimentation rate and C-reactive protein, and it is closely associated with giant cell art...
- bmj.com
It is clinically defined by subacute, bilateral aching pain and severe morning stiffness lasting longer than 45 minutes, localized primarily to the shoulder girdles, pelvic girdles, and neck
- nih.gov
Pathophysiologically, the condition involves periarticular inflammation characterized by bursitis, tenosynovitis, and synovitis, frequently accompanied by marked elevations in acute-phase reactants such as erythrocyte sedimentation rate and C-reactive protein, and it is closely associated with giant cell arteritis
Personalize your experience
Follow Polymyalgia rheumatica and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.